17218-Ovarian Cancer-NA-1530

Ovarian Cancer

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Address

7695 South Research Dr
Tempe, AZ 85284
P: (888) 972-2873

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.